Stopping osteoarthritis: Could recent heart research provide a clue?
Here’s a recent headline that I found confusing: Could the first drug that slows arthritis be here? It’s confusing because it depends on which of the more than 100 types of arthritis we’re discussing. We’ve had drugs that slow rheumatoid arthritis for decades. In fact, more than a dozen FDA-approved drugs can reduce, or even halt, joint damage in people with rheumatoid arthritis. We also have effective medications to slow or stop gout, another common type of arthritis. But the headline refers to osteoarthritis, the most common type of arthritis. And currently, no medications can safely and reliably slow the pace of this worsening joint disease. That’s one reason so many knee and hip replacements are performed: more than 1.2 million each year in the US alone. A drug that can slow down joint degeneration in osteoarthritis has long been the holy grail of arthritis treatments, because it could relieve pain and lessen suffering for millions of people help prevent the loss of function that accompanies osteoarthritis reduce the need for surgery, along with its attendant risks, expense, and time needed for recovery. And, needless to say, such a drug would generate enormous profits for the pharmaceutical company that comes up with it first. A study of heart disease might have identified a new treatment for osteoarthritis According to new research published in Annals of Internal Medicine, it’s possible that such a treatment exists, and is already i...
Seglentis contains 56 mg of celecoxib and 44 mg of tramadol and should be reserved for adults with severe refractory pain.FDA Approvals
Conclusions: In trials published from 2010 to 2019, M-M-RII continued to be safe and immunogenic in all age groups studied. These data, along with the results of earlier trials, indicate that the performance of the vaccine has been consistent across more than 30 years of postlicensure studies.
No abstract available
Social media can be hazardous, especially for women, but for healthcare professionals who care about their careers and their patients, maintaining a presence on social media is a must, say experts.Medscape Medical News
Purpose of review This review highlights recent research advances regarding the pathophysiology and treatment of gastroparesis. Recent findings Differences in brain activity have been identified on functional MRI imaging in gastroparesis patients with nausea. Abdominal pain is common in patients with gastroparesis and does not correlate with the severity of gastric emptying delay, though may be associated with depression and anxiety. Autonomic dysfunction may play an important role in the pathophysiology of gastroparesis. There is increasing sentiment that gastroparesis should be considered a part of the same sp...
Most common sequelae include functional mobility impairments, pulmonary abnormalities, and mental health disorders
Sufficient levels of iron in the blood might prevent about 1 in 10 diagnoses of coronary heart disease and reduce mortality risk. The good news: Lots of healthy foods have plenty of iron.
Self-administered external trigeminal nerve stimulation is superior to sham stimulation in relieving pain for patients with episodic migraine, results from a phase 3 study show.Medscape Medical News
Learn about hearing aids, personal sound amplification products, and the proposed change to how you can get hearing aids.
Researchers say men outnumber women in stroke therapy clinical trials, which means women may end up receiving less effective treatment.
More News: Arthritis | Blogging | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Gout | Harvard | Health | Heart | Heart Attack | Heart Disease | HIV AIDS | Insurance | Internal Medicine | Learning | Orthopaedics | Osteoarthritis | Pain | Pediatrics | Rheumatoid Arthritis | Rheumatology | Stroke | Study | Universities & Medical Training | Warnings | X-Ray